Join us for another episode of the Virtual Breakfast Series where we are joined by John Maraganore, founding CEO of Alnylam Pharmaceuticals, which he led for more than 20 years before stepping down as CEO at the end of 2021. In addition to pioneering the RNAi therapeutics space with his team at Alnylam, John has served as the Chair of BIO and is now stepping into the role of building new companies in the venture capital space as a venture partner with ARCH and as an advisor to Atlas Venture and RTW investments.